Money
Novadip Biosciences Secures €10.4 Million for Clinical Development
Novadip Biosciences has raised €10.4 million to advance its Phase 3 clinical trials and unlock additional venture debt from the European Investment Bank.
September 21, 2026, 12:40 PM·EU-Startups